INS and diabetes mellitus: Deletion of GPR4 is associated with lower blood pressure, lower binding to angiotensin II receptor, and increased insulin sensitivity (63, 64); these aspects are of particular interest as hypertension and diabetes are risk factors associated with COVID-19 mortality (4).